- Home
- / Lincoln Pharmaceuticals
Lincoln Pharmaceuticals
Stock Price
₹604.5
2024-03-12
Market Capitalization
₹12.8 B
2024-03-12
Revenue
₹6.2 B
FY, 2025
Lincoln Pharmaceuticals Summary
Company Summary
- Overview
- Lincoln Pharmaceuticals is a research-based company. It manufactures and markets various therapeutic molecules. The company offers products in the dosage forms of tablets, capsules, powders, injectables, syrups, and ointments.
- Type
- Public
- Status
- Active
- Founded
- 1979
- HQ
- Ahmedabad, IN | view all locations
- Website
- http://www.lincolnpharma.com
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
1 location detected
Ahmedabad, GJ HQ
India
Lincoln House, B/h, Satyam Complex, Science City Rd, Sola
Lincoln Pharmaceuticals Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹1.7B
- Gross profit (Q3, 2026)
- ₹1.1B
- Net income (Q3, 2026)
- ₹286.0M
- Cash (Q2, 2026)
- ₹229.9M
- EBIT (Q3, 2026)
- ₹350.2M
- Enterprise value
- $12.5B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026